Fuzheng Huayu Tablet in the treatment of Crohn's disease intestinal fibrosis: a prospective, multicenter, randomized controlled study
Phase 1
- Conditions
- Crohn's disease
- Registration Number
- ITMCTR2200005582
- Lead Sponsor
- Shanghai Tenth People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.Ages 18 to 80
2.Preoperative CDAI score <150
3.Laparoscopic ileocecal resection and one-stage anastomosis were performed
4.The pathological indication is fibrotic stenosis
Exclusion Criteria
1.Smokers who cannot quit smoking
2.Patients with diseases of heart, lung, liver, kidney and other organs
3.Malignant stenosis
4.Allergic to Fuzheng Huayu tablet
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BMI;CRP;CBC;
- Secondary Outcome Measures
Name Time Method